Welcome to the 2022 ASCP Annual Meeting!

The ASCP Annual Meeting is the premiere meeting each year in the field of psychopharmacology. Bringing together representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Steering Committee chaired by Drs. Susan Kornstein and Mark Rapaport with representation of the sectors that are part of the ASCP community lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, the pharmaceutical industry and academia comprise the 2022 Steering Committee. A Program Committee under the leadership of Drs. Erika Saunders and Lee Cohen are responsible for the review of all program submissions.

Join the American Society of Clinical Psychopharmacology for the
2022 Annual Meeting, May 31 – June 03, 2022 in Scottsdale, Arizona.

Submissions now open. Click Here

Submission Type	Deadline	Status	Submission Information
Panels & Workshops Overall (Chair) Proposals	November 1, 2021	CLOSED	Call For Proposals Panels & Workshops Submission Guidelines
Panels & Workshops Individual Presenter Proposals	December 10, 2021	CLOSED	Call For Proposals Panels & Workshops Submission Guidelines
New Investigator Awards	January 31, 2022	OPEN	Call For Proposals NIA Submission Guidelines
Posters & Individual Research Reports	January 31, 2022	OPEN	Call For Proposals Posters & IRR Submission Guidelines
Donald Klein Lifetime Achievement Award	February 15, 2022	OPEN	Call For Proposals
Paul Wender Best Paper in The Journal of Clinical Psychiatry Award	February 15, 2022	OPEN	Call For Proposals
Pharmaceutical Pipeline Presentations	February 17, 2022	OPEN	Call For Proposals Pharmaceutical Pipeline Submission Guidelines
Late-Breaking Posters	March 14, 2022	OPEN	Posters & IRR Submission Guidelines

* All deadlines are 5:00 PM Central U.S. Time

For more information, visit www.ASCPMeeting.org

The ASCP Annual Meeting brings together over 1200 academic and industry investigators, research pharmacists, and clinicians, including competitively selected New Investigator awardees. ASCP is joined by federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism, (NIAAA) and the Food and Drug Administration (FDA) to organize a program that emphasizes the presentation of information that has not been previously published or presented. For more information about the history and purpose of the ASCP Annual Meeting please click here.

In recent years, the ASCP Annual Meeting focus has been expanded to address a number of timely issues relevant to clinical research in psychiatry, including the translation of research into practice, the importance of regulatory issues, and pharmacogenetics and other means to personalizing interventions.

For more information, visit www.ASCPMeeting.org.